Refer China: City orders real-name regist for fever medication amid outbreak

-

The southern city of Foshan has required real-name registration for medication to treat chikungunya fever, while two cities in southeastern China have asked travellers returning from affected areas to monitor their health for signs of the mosquito-borne illness.

The list of drugs that require real-name registration for sale is as follows：

The market supervision bureau in Foshan, Guangdong province issued a public notice on Sunday asking all retail pharmacies to start real-name registration and to keep records when selling medications to treat symptoms of chikungunya, including fever, rashes and joint pain.

This practice was also used during the Covid-19 pandemic to help mainland Chinese authorities track potential cases that were not reported.

-ad

China's National Health Commission and the National Administration of Traditional Chinese Medicine (NATCM) on Thursday released the 2025 protocol for chikungunya fever (CHIK) to guide treatment and improve standardized care across medical institutions.

According to the protocol, which is based on the 2008 edition, CHIK is an acute infectious disease caused by the chikungunya virus (CHIKV), transmitted through the bite of Aedes mosquitoes. It is clinically characterized by fever, joint pain, and rash.

Chikungunya fever is widely prevalent in tropical and subtropical regions around the world, with its geographic spread continuing to expand. In China, Aedes mosquitoes are widely distributed, and in recent years, multiple local outbreaks have occurred due to imported cases.

There is currently no available vaccine for the chikungunya virus in China. Preventive measures focus on eliminating mosquito breeding sites to reduce mosquito density. Individuals are advised to use mosquito coils, repellents, and mosquito nets to prevent mosquito bites.

Source :

Editor: Crystal H

Refer China

City orders real-name regist for fever medication amid outbreak

-

No comments:

Post a Comment